ミシガン州における血液がんの臨床試験
ミシガン州内の拠点で、血液がんに関する22件の研究が参加者を募集しています。
ミシガン州内の都市
公式研究テキスト（英語）
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Karmanos Cancer Institute ( Site 0047), Detroit
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- 他68件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- Start Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07572006A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- University of Michigan Health System, Ann Arbor
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT04634552Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 22, Ann Arbor
被験者募集中第3相
18歳〜71歳 · 全性別 · 2026/09/23更新 · NCT07504458Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- 他33件
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/17更新 · NCT04242095A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- University of Michigan, Ann Arbor
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07195916Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of Michigan, Ann Arbor
- Wayne State University School of Medicine, Detroit
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT07007312Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Karmanos Cancer Institute, Detroit
- Henry Ford Cancer Institute, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT06001788A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- University of Michigan, Ann Arbor
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/10更新 · NCT06823167PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- Barbara Ann Karmanos Cancer Institute, Detroit
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT06665100A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07424833A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Michigan, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
- 他2件
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
- Uni Of Michigan Health System, Ann Arbor
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/11更新 · NCT06401356Increasing Knowledge and Interest in Cancer Clinical Trials
- Wayne State University/Karmanos Cancer Institute, Detroit
被験者募集中健康なボランティア歓迎
21歳以上 · 全性別 · 2026/06/10更新 · NCT06501040Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- West Michigan Cancer Center, Kalamazoo
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/07更新 · NCT02269592A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
被験者募集中第3相
2歳〜18歳 · 全性別 · 2026/05/05更新 · NCT05711667A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Karmanos Cancer Institute, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/13更新 · NCT05735184HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
- Henry Ford hospital, Detroit
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/02/24更新 · NCT03850366Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
- Karmanos Cancer Institute, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/11更新 · NCT07036133A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
- Corewell Health, Grand Rapids
被験者募集中観察研究
18歳以上 · 全性別 · 2025/06/25更新 · NCT05768269Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- C.S. Mott Children's Hospital, Ann Arbor
被験者募集中第1相
1歳〜21歳 · 全性別 · 2024/12/06更新 · NCT05476770ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。